메뉴 건너뛰기




Volumn 50, Issue 13, 2005, Pages 3113-3125

Validation of the Monte Carlo simulator GATE for indium-111 imaging

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER SIMULATION; COMPUTERIZED TOMOGRAPHY; DATA ACQUISITION; INDIUM; MATHEMATICAL MODELS; MONTE CARLO METHODS; PHOTOMULTIPLIERS;

EID: 21344431679     PISSN: 00319155     EISSN: None     Source Type: Journal    
DOI: 10.1088/0031-9155/50/13/010     Document Type: Article
Times cited : (62)

References (25)
  • 1
    • 2942748643 scopus 로고    scopus 로고
    • Monte Carlo simulation in PET and SPECT instrumentation using GATE
    • Assié K et al 2004 Monte Carlo simulation in PET and SPECT instrumentation using GATE Nucl. Instrum. Methods. A 527 180-9
    • (2004) Nucl. Instrum. Methods. A , vol.527 , pp. 180-189
    • Assié, K.1
  • 2
    • 0032898060 scopus 로고    scopus 로고
    • MIRD Pamplet no. 17: The dosimetry of nonuniform activity distributions - Radionuclide S values at the voxel level
    • Bolch W E et al 1999 MIRD Pamplet no. 17: the dosimetry of nonuniform activity distributions - radionuclide S values at the voxel level J. Nucl. Med. 40 11S-36S
    • (1999) J. Nucl. Med. , vol.40
    • Bolch, W.E.1
  • 4
    • 0033227592 scopus 로고    scopus 로고
    • Preclinical evaluation of 90Y-labeled anti-CD20 monoclonal antibody for treatment of non-Hodgkin's lymphoma
    • Chinn P C, Leonard J E, Rosenberg J, Hanna N and Anderson D R 1999 Preclinical evaluation of 90Y-labeled anti-CD20 monoclonal antibody for treatment of non-Hodgkin's lymphoma Int. J. Oncol. 15 1017-25
    • (1999) Int. J. Oncol. , vol.15 , pp. 1017-1025
    • Chinn, P.C.1    Leonard, J.E.2    Rosenberg, J.3    Hanna, N.4    Anderson, D.R.5
  • 5
    • 0042929352 scopus 로고    scopus 로고
    • Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,D-Phe1,Tyr3]-octreotide, a promising somatostatin analogue for radionuclide therapy
    • De Jong M, Bakker W H, Krenning E P, Breeman W A, van der Pluijm M E and Bernard B F 1997 Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,D-Phe1,Tyr3]-octreotide, a promising somatostatin analogue for radionuclide therapy Eur. J. Nucl. Med. 24 368-71
    • (1997) Eur. J. Nucl. Med. , vol.24 , pp. 368-371
    • De Jong, M.1    Bakker, W.H.2    Krenning, E.P.3    Breeman, W.A.4    Van Der Pluijm, M.E.5    Bernard, B.F.6
  • 6
    • 0033623357 scopus 로고    scopus 로고
    • Accuracy of 131I tumor quantification in radioimmunotherapy using SPECT imaging with an ultra-high-energy collimator: Monte Carlo study
    • Dewaraja Y K, Ljungberg M and Koral K F 2000 Accuracy of 131I tumor quantification in radioimmunotherapy using SPECT imaging with an ultra-high-energy collimator: Monte Carlo study J. Nucl. Med. 41 1760-7
    • (2000) J. Nucl. Med. , vol.41 , pp. 1760-1767
    • Dewaraja, Y.K.1    Ljungberg, M.2    Koral, K.F.3
  • 8
    • 44949283598 scopus 로고
    • Newer approaches to the radiolabeling of monoclonal antibodies by use of metal chelates
    • Gansow O A 1991 Newer approaches to the radiolabeling of monoclonal antibodies by use of metal chelates Int. J. Rad. Appl. Instrum. B 18 369-81
    • (1991) Int. J. Rad. Appl. Instrum. B , vol.18 , pp. 369-381
    • Gansow, O.A.1
  • 10
    • 0028881834 scopus 로고
    • Development of a SPECT-based three-dimensional treatment planning system for radioimmunotherapy
    • Giap H B, Macey D J and Podoloff D A 1995 Development of a SPECT-based three-dimensional treatment planning system for radioimmunotherapy J. Nucl. Med. 36 1885-94
    • (1995) J. Nucl. Med. , vol.36 , pp. 1885-1894
    • Giap, H.B.1    Macey, D.J.2    Podoloff, D.A.3
  • 11
    • 0042630427 scopus 로고    scopus 로고
    • GEANT4: A simulation toolkit
    • GEANT4 Collaboration 2002 GEANT4: a simulation toolkit SLAC Report SLAC-PUB-9350
    • (2002) SLAC Report SLAC-PUB-9350
  • 12
    • 0005824598 scopus 로고    scopus 로고
    • Variance reduction techniques
    • ed M Ljungberg, S E Strand and M A King (Bristol: Institute of Physics Publishing)
    • Haynor D R 1998 Variance reduction techniques Monte Carlo Calculations in Nuclear Medicine ed M Ljungberg, S E Strand and M A King (Bristol: Institute of Physics Publishing) pp 13-24
    • (1998) Monte Carlo Calculations in Nuclear Medicine , pp. 13-24
    • Haynor, D.R.1
  • 14
    • 5744251917 scopus 로고    scopus 로고
    • GATE: A simulation toolkit for PET and SPECT
    • Jan S et al 2004 GATE: a simulation toolkit for PET and SPECT Phys. Med. Biol. 49 4543-61
    • (2004) Phys. Med. Biol. , vol.49 , pp. 4543-4561
    • Jan, S.1
  • 16
    • 0942288051 scopus 로고    scopus 로고
    • Validation of the GATE Monte Carlo simulation platform for modelling a CsI(Tl) scintillation camera dedicated to small-animal imaging
    • Lazaro D et al 2004 Validation of the GATE Monte Carlo simulation platform for modelling a CsI(Tl) scintillation camera dedicated to small-animal imaging Phys. Med. Biol. 49 271-85
    • (2004) Phys. Med. Biol. , vol.49 , pp. 271-285
    • Lazaro, D.1
  • 17
    • 0037222431 scopus 로고    scopus 로고
    • 3D absorbed dose calculations based on SPECT: Evaluation for 111-In/90-Y therapy using Monte Carlo simulations
    • Ljungberg M, Frey E, Sjogreen K, Liu X, Dewaraja Y and Strand S E 2003 3D absorbed dose calculations based on SPECT: evaluation for 111-In/90-Y therapy using Monte Carlo simulations Cancer Biother. Radiopharm. 18 99-107
    • (2003) Cancer Biother. Radiopharm. , vol.18 , pp. 99-107
    • Ljungberg, M.1    Frey, E.2    Sjogreen, K.3    Liu, X.4    Dewaraja, Y.5    Strand, S.E.6
  • 18
    • 0142063357 scopus 로고    scopus 로고
    • GATE, a Geant4-based simulation platform for PET imaging integrating movement and time management
    • Santin G, Strul D, Lazaro D, Breton V and Morel C 2003 GATE, a Geant4-based simulation platform for PET imaging integrating movement and time management IEEE Trans. Nucl. Sci. 50 1516-21
    • (2003) IEEE Trans. Nucl. Sci. , vol.50 , pp. 1516-1521
    • Santin, G.1    Strul, D.2    Lazaro, D.3    Breton, V.4    Morel, C.5
  • 19
    • 0025144572 scopus 로고
    • Treatment planning for internal radionuclide therapy: Three-dimentional dosimetry for nonuniformly distributed radionuclides
    • Sgouros G, Barest G, Thekkumthala J, Chui C, Mohan R, Bigler R E and Zanzonico P B 1990 Treatment planning for internal radionuclide therapy: three-dimentional dosimetry for nonuniformly distributed radionuclides J. Nucl. Med. 31 1884-91
    • (1990) J. Nucl. Med. , vol.31 , pp. 1884-1891
    • Sgouros, G.1    Barest, G.2    Thekkumthala, J.3    Chui, C.4    Mohan, R.5    Bigler, R.E.6    Zanzonico, P.B.7
  • 20
    • 16744365716 scopus 로고    scopus 로고
    • MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates
    • Siegel J A et al 1999 MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates J. Nucl. Med. 40 37S-61S
    • (1999) J. Nucl. Med. , vol.40
    • Siegel, J.A.1
  • 21
    • 0042388275 scopus 로고    scopus 로고
    • Quantitative accuracy of dopaminergic neurotransmission imaging with (123)I SPECT
    • Soret M, Koulibaly P M, Darcourt I, Hapdey S and Buvat I 2003 Quantitative accuracy of dopaminergic neurotransmission imaging with (123)I SPECT J. Nucl. Med. 44 1184-93
    • (2003) J. Nucl. Med. , vol.44 , pp. 1184-1193
    • Soret, M.1    Koulibaly, P.M.2    Darcourt, I.3    Hapdey, S.4    Buvat, I.5
  • 22
    • 0030002992 scopus 로고    scopus 로고
    • MIRDOSE: Personal computer software for internal dose assessment in nuclear medicine
    • Stabin M 1996 MIRDOSE:personal computer software for internal dose assessment in nuclear medicine J. Nucl. Med. 37 538-46
    • (1996) J. Nucl. Med. , vol.37 , pp. 538-546
    • Stabin, M.1
  • 24
    • 0032748607 scopus 로고    scopus 로고
    • 90Y-labeled anti-CD20 monoclonal antibody
    • 90Y-labeled anti-CD20 monoclonal antibody Clin. Cancer Res. 5 3281s-6s
    • (1999) Clin. Cancer Res. , vol.5
    • Wiseman, G.A.1
  • 25
    • 0033922969 scopus 로고    scopus 로고
    • Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma
    • Wiseman G A et al 2000 Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma Eur. J. Nucl. Med. 27 766-77
    • (2000) Eur. J. Nucl. Med. , vol.27 , pp. 766-777
    • Wiseman, G.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.